---
title: "3 Growth Stocks With Earnings Growth Over 32%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304895923.md"
description: "The article highlights three growth stocks with earnings growth over 32%: Vaxcyte, a vaccine developer with strong clinical potential; Penguin Solutions, an AI data center provider seeing robust enterprise demand; and Palantir Technologies, leveraging its AI platform for government and commercial clients. These companies are selected for their financially resilient profiles and strong profit expansion forecasts amidst the broader shift toward AI infrastructure."
datetime: "2026-11-09T18:34:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304895923.md)
  - [en](https://longbridge.com/en/news/304895923.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304895923.md)
generator: "portal-rs"
---

# 3 Growth Stocks With Earnings Growth Over 32%

Google’s rapid push into AI chips is reshaping expectations for what high growth really looks like. Capital is flowing toward businesses that can scale earnings, not just headlines. That is where financially sound companies with strong profit expansion forecasts start to matter. This article examines three such stocks from a curated high growth shortlist and explores why they could merit a place on your watchlist right now.

The three stocks highlighted here offer a compelling starting point if you want exposure to financially resilient high growth potential businesses with strong earnings expansion forecasts. However, if you want the pick of this theme, these 90 best high growth potential stocks are the best of the best.

## Vaxcyte (PCVX)

Vaxcyte is a clinical stage vaccine developer focused on conjugate and protein based shots for serious bacterial infections, with its late stage pneumococcal programs VAX-24 and VAX-31 central to its healthy high growth potential profile and backed by a roughly US$10.1b market cap.

The bullish analyst Narrative on Simply Wall St argues that Vaxcyte epitomises the Healthy high growth potential theme because its late stage pneumococcal vaccine work could translate strong clinical data into meaningful earnings power if the programs clear their remaining hurdles.

> *OPUS-1’s use of a tighter 0.667 OPA GMR margin and broad non inferiority against existing adult vaccines sets a higher comparative bar for any future higher valency entrants, which could support longer lasting pricing power and gross margins if Vaxcyte becomes the reference product for adult PCVs.*

The real swing factor is how one emerging supply side decision shapes long term demand quality and the earnings profile that follows.

That supply decision is the hinge. Read the full narrative for Vaxcyte to see how pricing power, execution risk and competitive timing could reshape Vaxcyte’s long term earnings profile.

## Penguin Solutions (PENG)

Penguin Solutions builds and runs AI focused data centers and related memory and LED products, with its Advanced Computing arm tying it directly to the Healthy high growth potential theme, alongside Integrated Memory at about US$924 million, Optimized LED at roughly US$249 million, and a market value near US$2.5b.

Penguin Solutions is pulling more of its future into AI infrastructure work, and the analyst consensus Narrative on Simply Wall St highlights how that shift connects expected earnings expansion to very specific customer spending plans rather than just broad hype around artificial intelligence.

> *Accelerating adoption of AI and high performance computing across major enterprise verticals, together with Penguin Solutions’ report that AI aligned businesses made up 78% of Q4 FY26 net sales and grew very strongly year over year, keeps the earlier theme of strong turnkey compute demand live and points to further revenue growth potential as these customers scale out AI infrastructure.*

What happens to that outlook if one pressure on how fast those high value AI projects convert into cash quietly starts to bite?

If that conversion pressure is what you are weighing, the full narrative for Penguin Solutions outlines how Penguin Solutions’ AI momentum could still accelerate as project timelines and cash flows slowly decouple.

## Palantir Technologies (PLTR)

Palantir Technologies builds software that lets governments and large enterprises bring scattered data into one place, then turn it into AI driven decisions. This is central to the Healthy high growth potential theme, with around US$3.6b from Commercial, US$3.7b from Government and a roughly US$386.4b market cap.

Palantir taps into the Healthy high growth potential theme by turning AI from a buzzword into a working tool inside large organisations. According to BlackGoat, an investor in the Simply Wall St Community, the company’s recent momentum reflects how powerful that shift can be when it reaches scale.

> *The global shift toward AI-driven transformation is a significant growth catalyst for Palantir, with its Artificial Intelligence Platform (AIP) enabling seamless integration of AI into enterprise operations.*

What matters next is how one quiet change in where this AI driven demand comes from ends up reshaping growth quality and margins.

As that mix of commercial and government demand shifts, the full narrative for Palantir Technologies shows how Palantir Technologies’ AI flywheel, contract quality and risks could still be getting underestimated.

## Seeking Fresh Alternatives Before They Fly?

Fresh breakouts often move first, then the story catches up. Momentum can shift quickly, and under the radar ideas rarely stay quiet for long, so timely analysis can be important.

-   Spot early movers in smaller names before momentum headlines catch up by scanning the curated 10 elite penny stocks with strong financials while they are still under the radar.
-   Follow developments in digital money infrastructure by tracking leaders inside the focused 18 cryptocurrency and blockchain stocks before broader attention changes typical entry points.
-   Review cash rich companies with resilient balance sheets by filtering for a hand picked list of solid balance sheet and fundamentals (25 results) while current valuation levels still meet your criteria.

### Related Stocks

- [PCVX.US](https://longbridge.com/en/quote/PCVX.US.md)
- [PENG.US](https://longbridge.com/en/quote/PENG.US.md)
- [PLTR.US](https://longbridge.com/en/quote/PLTR.US.md)
- [PENU.US](https://longbridge.com/en/quote/PENU.US.md)
- [PLA.US](https://longbridge.com/en/quote/PLA.US.md)
- [PLIB.US](https://longbridge.com/en/quote/PLIB.US.md)
- [PLOO.US](https://longbridge.com/en/quote/PLOO.US.md)
- [PLT.US](https://longbridge.com/en/quote/PLT.US.md)
- [PLTA.US](https://longbridge.com/en/quote/PLTA.US.md)
- [PLTD.US](https://longbridge.com/en/quote/PLTD.US.md)
- [PLTG.US](https://longbridge.com/en/quote/PLTG.US.md)
- [PLTL.US](https://longbridge.com/en/quote/PLTL.US.md)
- [PLTU.US](https://longbridge.com/en/quote/PLTU.US.md)
- [PLTW.US](https://longbridge.com/en/quote/PLTW.US.md)
- [PLTY.US](https://longbridge.com/en/quote/PLTY.US.md)
- [PLTZ.US](https://longbridge.com/en/quote/PLTZ.US.md)
- [PLYY.US](https://longbridge.com/en/quote/PLYY.US.md)
- [PTIR.US](https://longbridge.com/en/quote/PTIR.US.md)

## Related News & Research

- [OLIGO Security Achieves FedRAMP® Class D (High) Certification Through Palantir’s FedStart Program | PLTR Stock News](https://longbridge.com/en/news/306146320.md)
- [Palantir Technologies (PLTR) Ties Up Defense AI Deal As UK NHS Rivalry Returns](https://longbridge.com/en/news/305865049.md)
- [Penguin Solutions (PENG) Launches New AI System, Is It Still 49% Undervalued?](https://longbridge.com/en/news/305939446.md)
- [PCVX: Adult VAX-31 met pivotal endpoints; infant data are expected by H1 2027](https://longbridge.com/en/news/305952147.md)
- [Is Vaxcyte (PCVX) Undervalued On Wider Losses And A Softer Share Price?](https://longbridge.com/en/news/305544389.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**